Prognostic significance of HLA EMR8-5 immunohistochemically analyzed expression in osteosarcoma

Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients’ prognosis

(2013) Haibo Zhu et al.   Diagnostic Pathology

Expression of Aurora Kinase A and B in chondrosarcoma and its relationship with the prognosis

(2012) Xiaohui Liang et al.   Diagnostic Pathology

Establishment of a monoclonal anti-pan HLA class I antibody suitable for immunostaining of formalin-fixed tissue: Unusually high frequency of down-regulation in breast cancer tissues

(2012) Toshihiko Torigoe et al.   PATHOLOGY INTERNATIONAL

Clinical implication of HLA class I expression in breast cancer

(2011) Koichi Kaneko et al.   BMC CANCER

Osteosarcoma – conventional treatment vs. gene therapy

(2010) Mei Lin Tan et al.   CANCER BIOLOGY & THERAPY

Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma

(2009) M. S. Kim et al.   ANNALS OF ONCOLOGY

Human leukocyte antigen class I down-regulation in muscle-invasive bladder cancer: Its association with clinical characteristics and survival after cystectomy

(2009) Ichiya Homma et al.   CANCER SCIENCE

The kinase Mirk is a potential therapeutic target in osteosarcoma

(2009) C. Yang et al.   CARCINOGENESIS

Molecular pathological approaches to human tumor immunology

(2009) Noriyuki Sato et al.   PATHOLOGY INTERNATIONAL

Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma

(2008) Y Mizukami et al.   BRITISH JOURNAL OF CANCER

Molecular mechanisms of MHC class I abnormalities and APM components in human tumors

(2008) Barbara Seliger   CANCER IMMUNOLOGY IMMUNOTHERAPY

HLA-class I expression in gastric cancer

(2008) Sumiya Ishigami et al.   JOURNAL OF SURGICAL ONCOLOGY